The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro.
Open accessAbstract
The sulfated polysaccharides dextran sulfate and heparin have proved to be potent and selective inhibitors of human immunodeficiency virus type 1 (HIV-1) in vitro. Dextran sulfate (Mr 5000) and heparin (Mr 15,000) completely protected MT-4 cells against HIV-1-induced cytopathogenicity at a concentration of 25 micrograms/ml. Their 50% inhibitory concentrations were 9.1 micrograms/ml (dextran sulfate) and 7.0 micrograms/ml (heparin), respectively. No toxicity for the host cells was observed with these compounds at a concentration of 625 micrograms/ml. The anti-HIV-1 activity of heparins of various molecular weights correlated well with their anticoagulant activity. On the other hand, with dextran sulfates of low molecular weight (5000, 8000) a significant inhibitory effect on HIV-1 was achieved at a concentration that was not markedly inhibitory to the blood coagulation process. Dextran sulfate and heparin were not inhibitory to HIV-1 reverse transcriptase unless they were used at concentrations in excess of those that inhibited HIV-1 replication. They were highly effective against HIV-1 replication even when present only during the 2-hr virus adsorption period. Studies using radiolabeled HIV-1 virions indicated that dextran sulfate and heparin inhibit virus adsorption to the host cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038
The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
Fischl, M. A., Richman, D. D., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Schooley, R. T., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707233170401 · Cited by 2,995
Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS
Levy, J. A., Hoffman, A. D., Kramer, S. M., Landis, J. A., Shimabukuro, J. M., & Oshiro, L. S. (1984) · Science · doi:10.1126/science.6206563 · Cited by 1,436
Furman, P. A., Fyfe, J. A., St Clair, M. H., Weinhold, K., Rideout, J. L., Freeman, G. A., Lehrman, S. N., Bolognesi, D. P., Broder, S., & Mitsuya, H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8333 · Cited by 1,347
Isolation of Human T-Cell Leukemia Virus in Acquired Immune Deficiency Syndrome (AIDS)
Gallo, R. C., Sarin, P. S., Gelmann, E. P., Robert-Guroff, M., Richardson, E., Kalyanaraman, V. S., Mann, D., Sidhu, G. D., Stahl, R. E., Zolla-Pazner, S., et al. (1983) · Science · doi:10.1126/science.6601823 · Cited by 1,238
Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque Assay
Harada, S., Koyanagi, Y., & Yamamoto, N. (1985) · Science · doi:10.1126/science.2992081 · Cited by 857
Yarchoan, R., Weinhold, K., Lyerly, H. K., Gelmann, E., Blum, R., Shearer, G., Mitsuya, H., Collins, J., Myers, C., Klecker, R., et al. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92808-4 · Cited by 802
Folkman, J., Langer, R., Linhardt, R. J., Haudenschild, C., & Taylor, S. (1983) · Science · doi:10.1126/science.6192498 · Cited by 619
Mitsuya, H., Looney, D. J., Kuno, S., Ueno, R., Wong-Staal, F., & Broder, S. (1988) · Science · doi:10.1126/science.2452480 · Cited by 463
Ito, M., Baba, M., Sato, A., Pauwels, R., Clercq, E. D., & Shigeta, S. (1987) · Antiviral Research · doi:10.1016/0166-3542(87)90018-0 · Cited by 319
Self-citationSuramin: A potent inhibitor of the reverse transcriptase of RNA tumor viruses
De Clercq, E. (1979) · Cancer Letters · doi:10.1016/0304-3835(79)90017-x · Cited by 288
Self-citationBroder, S., Collins, J., Markham, P., Redfield, R., Hoth, D., Groopman, J., Gallo, R., Yarchoan, R., Clifford Lane, H., Klecker, R., et al. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90002-9 · Cited by 209
DEXTRAN SULPHATE, A POTENT ANTI-HIV AGENT IN VITRO HAVING SYNERGISM WITH ZIDOVUDINE
Ueno, R., & Kuno, S. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90681-7 · Cited by 208
Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus
Pauwels, R., De Clercq, E., Desmyter, J., Balzarini, J., Goubau, P., Herdewijn, P., Vanderhaeghe, H., & Vandeputte, M. (1987) · Journal of Virological Methods · doi:10.1016/0166-0934(87)90002-4 · Cited by 186
Self-citationHoylaerts, M., Owen, W. G., & Collen, D. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91066-5 · Cited by 117
Mitsuya, H., Guo, H.-G., Cossman, J., Megson, M., Reitz, M. S., & Broder, S. E. (1984) · Science · doi:10.1126/science.6206569 · Cited by 62
Sensitivity and Precision of Activated Partial Thromboplastin Time (APTT) Methods
Refsum, N., Collen, D., Godal, H. C., Janson, T. L., Mannucci, P. M., Nilsson, I. M., & Gilhuus‐Moe, C. C. (1978) · Scandinavian Journal of Haematology · doi:10.1111/j.1600-0609.1978.tb01559.x · Cited by 15
Cited by
Kilby, J. M., Hopkins, S., Venetta, T. M., DiMassimo, B., Cloud, G. A., Lee, J. Y., Alldredge, L., Hunter, E., Lambert, D., Bolognesi, D., et al. (1998) · Nature Medicine · doi:10.1038/3293 · Cited by 987
Pathogenesis of human immunodeficiency virus infection
Levy, J. A. (1993) · Microbiological Reviews · doi:10.1128/mr.57.1.183-289.1993 · Cited by 839
Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives
Pauwels, R., Andries, K., Desmyter, J., Schols, D., Kukla, M. J., Breslin, H. J., Raeymaeckers, A., Gelder, J. V., Woestenborghs, R., Heykants, J., et al. (1990) · Nature · doi:10.1038/343470a0 · Cited by 756
Self-citationMolecular Targets for AIDS Therapy
Mitsuya, H., Yarchoan, R., & Broder, S. (1990) · Science · doi:10.1126/science.1699273 · Cited by 732
Baba, M., Snoeck, R., Pauwels, R., & de Clercq, E. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.11.1742 · Cited by 544
Self-citation
Metadata
- Authors
- Baba, M., Pauwels, R., Balzarini, J., Arnout, J., Desmyter, J., & De Clercq, E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1988-08
- Volume
- 85
- Issue
- 16
- Pages
- 6132-6136
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2020933095
- Cited by
- 465
- References
- 17
- FWCI
- 7.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.